362 related articles for article (PubMed ID: 15308580)
1. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
[TBL] [Abstract][Full Text] [Related]
2. [Anti-hypertensive effects of PPARgamma ligands through the inhibition of Rho/Rho kinase pathway].
Wakino S; Hayashi K
Nihon Rinsho; 2005 Apr; 63(4):693-9. PubMed ID: 15828239
[TBL] [Abstract][Full Text] [Related]
3. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
[TBL] [Abstract][Full Text] [Related]
4. Rho-kinase inhibition suppresses bladder hyperactivity in spontaneously hypertensive rats.
Rajasekaran M; Wilkes N; Kuntz S; E Albo M
Neurourol Urodyn; 2005; 24(3):295-300. PubMed ID: 15791631
[TBL] [Abstract][Full Text] [Related]
5. SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase.
Marsh HN; Dubreuil CI; Quevedo C; Lee A; Majdan M; Walsh GS; Hausdorff S; Said FA; Zoueva O; Kozlowski M; Siminovitch K; Neel BG; Miller FD; Kaplan DR
J Cell Biol; 2003 Dec; 163(5):999-1010. PubMed ID: 14662744
[TBL] [Abstract][Full Text] [Related]
6. Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation.
Tölle M; Giebing G; Tietge UJ; Jankowski J; Jankowski V; Henning L; Hörl MP; Weiss W; Zidek W; van der Giet M
J Hypertens; 2006 Oct; 24(10):1991-2000. PubMed ID: 16957559
[TBL] [Abstract][Full Text] [Related]
7. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
Ying Z; Jin L; Palmer T; Webb RC
Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.
Fukuda N; Hu WY; Teng J; Chikara S; Nakayama M; Kishioka H; Kanmatsuse K
Atherosclerosis; 2002 Aug; 163(2):229-39. PubMed ID: 12052469
[TBL] [Abstract][Full Text] [Related]
10. [Expression of peroxisome proliferator-activated receptors Y changes with age in vascular smooth muscle cells of spontaneously hypertensive rat].
Di ZL; Niu XL; Wei J; Li YQ; Chen GL; Wang NP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):204-7. PubMed ID: 16608075
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
Cruzado MC; Risler NR; Miatello RM; Yao G; Schiffrin EL; Touyz RM
Am J Hypertens; 2005 Jan; 18(1):81-7. PubMed ID: 15691621
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.
Martín A; Pérez-Girón JV; Hernanz R; Palacios R; Briones AM; Fortuño A; Zalba G; Salaices M; Alonso MJ
J Hypertens; 2012 Feb; 30(2):315-26. PubMed ID: 22179086
[TBL] [Abstract][Full Text] [Related]
14. Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells.
Palen DI; Belmadani S; Lucchesi PA; Matrougui K
Cardiovasc Res; 2005 Nov; 68(2):268-77. PubMed ID: 15967421
[TBL] [Abstract][Full Text] [Related]
15. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
Han YJ; Hu WY; Piano M; de Lanerolle P
Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells.
Wakino S; Kintscher U; Liu Z; Kim S; Yin F; Ohba M; Kuroki T; Schönthal AH; Hsueh WA; Law RE
J Biol Chem; 2001 Dec; 276(50):47650-7. PubMed ID: 11598137
[TBL] [Abstract][Full Text] [Related]
17. Soluble form of vascular cell adhesion molecule 1 induces migration and proliferation of vascular smooth muscle cells.
Lee HM; Kim HJ; Won KJ; Choi WS; Park SH; Song H; Park PJ; Park TK; Lee CK; Kim B
J Vasc Res; 2008; 45(3):259-68. PubMed ID: 18182825
[TBL] [Abstract][Full Text] [Related]
18. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
20. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.
Tabet F; Schiffrin EL; Callera GE; He Y; Yao G; Ostman A; Kappert K; Tonks NK; Touyz RM
Circ Res; 2008 Jul; 103(2):149-58. PubMed ID: 18566342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
